Search

everythinglearnresearchcommunity

for

Search:↓

Flutamide treatment showed no significant changes in mice vaginal mucosa.

The study concluded that hirsutism is most common in women aged 14 to 48, often caused by PCOS, and can be effectively treated with Nd YAG laser and IPL.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

Finasteride does not increase the risk of depression or suicide.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Mutations in certain receptors can cause diseases and offer new treatment options.

Non-obese women with hair loss have higher heart disease risk.

Autologous growth factor concentrate therapy shows promise for treating early-stage hair loss safely and effectively.

Korean patients with androgenetic alopecia may have a higher risk of heart-related health issues and could benefit from early heart screening and healthier lifestyles.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

New genes found linked to balding, may help develop future treatments.

Laser therapy and hair growth factors significantly improve hair density in male baldness.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Higher energy, longer exposure, and pulse irradiation improve hair density in androgenetic alopecia treatment.

Early diagnosis and treatment of NCCAH can improve symptoms and fertility.

FOXC1 boosts SFRP1 in hair loss, suggesting new treatments.

Androgens increase a growth factor in hair cells by creating reactive oxygen species, and antioxidants might help treat hair loss.

Hair loss linked to higher heart disease risk in both men and women.

Wnt/β-catenin and TGF-β pathways affect hair loss, and activating Wnt/β-catenin could be a potential treatment.

PRP growth factor concentrations vary, no significant hair growth difference found.

Found different long non-coding RNAs in balding Chinese men, which may help create new treatments.

c-kit affects hair growth and color in alopecia areata and androgenetic alopecia.

Finasteride helps female-pattern hair loss.

Stem cell therapy, particularly using certain types of cells, shows promise for treating hair loss by stimulating hair growth and development, but more extensive trials are needed to confirm these findings.

Using micro-needling, low-level laser therapy, and platelet-rich plasma together significantly improves hair growth in people with hair loss.

Lifestyle changes can help manage androgenetic alopecia.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.